UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005331
Receipt number R000006338
Scientific Title Comparison of the effect on vascular endothelial function and systemic metabolism between Liraglutide and insulin Glargine in patients with type 2 diabetes -prospective randomized controlled trial-
Date of disclosure of the study information 2011/03/28
Last modified on 2016/03/28 09:36:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparison of the effect on vascular endothelial function and systemic metabolism between Liraglutide and insulin Glargine in patients with type 2 diabetes -prospective randomized controlled trial-

Acronym

Study for the effects of Liraglutide on vascular endothelial function and systemic metabolism in patients with type 2 diabetes

Scientific Title

Comparison of the effect on vascular endothelial function and systemic metabolism between Liraglutide and insulin Glargine in patients with type 2 diabetes -prospective randomized controlled trial-

Scientific Title:Acronym

Study for the effects of Liraglutide on vascular endothelial function and systemic metabolism in patients with type 2 diabetes

Region

Japan


Condition

Condition

type 2 diabetes mellitus

Classification by specialty

Medicine in general Cardiology Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To compare the effects on arteriosclerosis between Liraglutide and insulin Glargine in patients with type 2 diabetes

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Phase IV


Assessment

Primary outcomes

Change in FMD (Flow mediated dilatation)

Key secondary outcomes

1) glucose and lipid metabolism, 2) beta cell function, 3) changes in TBI(Toe-brachial index) and Task force monitor, 4) several biomarkers (adipokines, oxidative stress, etc)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Liraglutide

Interventions/Control_2

Insulin Glargine

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) patients with type 2 diabetes using glimepiride (0.5mg-2mg) and/or metformin and/or DPP-4 inhibitor, 2) HbA1c 7.4-10.5% (NGSP), 3) blood pressure and lipids are well controlled
4) written informed consent

Key exclusion criteria

1) patients who received insulin injection therapy, 2) severe hepatic dysfunction, renal dysfunction, heart failure, 3) history of angina, myocardial infarction, stroke or other arteriosclerotic diseases, 4) patients who receive more than three antihypertensive agents, 5) patients who receive more than two antidyslipidemia agents, 6) history of anaphylaxis of liragrutide or insulin glargine, 7) pregnancy, 8) patients who are inadequate to enter this study due to the other reasons by physician's judgments

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hideaki Miyoshi

Organization

Hokkaido University Hospital

Division name

Department of Internal Medicine II

Zip code


Address

Nishi 5, Kita 14, Kita-ku, Sapporo, Hokkaido, Japan

TEL

011-706-5915

Email

hmiyoshi@med.hokudai.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hideaki Miyoshi

Organization

Hokkaido University Hospital

Division name

Department of Internal Medicine II

Zip code


Address

Nishi 5, Kita 14, Kita-ku, Sapporo, Hokkaido, Japan

TEL

011-706-5915

Homepage URL


Email

hmiyoshi@med.hokudai.ac.jp


Sponsor or person

Institute

Hokkaido University Hospital

Institute

Department

Personal name



Funding Source

Organization

The Waksman Foundation of Japan inc.

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海道大学病院(北海道)、青木内科クリニック(北海道)、大塚眼科(北海道)、大通り内科クリニック(北海道)、小笠原クリニック札幌病院附属外来プラザ(北海道)、小野百合内科クリニック(北海道)、クラーク病院(北海道)、栗原内科(北海道)、桑園中央病院(北海道)、北海道社会保険病院(北海道)、北海道中央労災病院せき損センター(北海道)、萬田記念病院(北海道)、時計台病院(北海道)


Other administrative information

Date of disclosure of the study information

2011 Year 03 Month 28 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0135854

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 03 Month 28 Day

Date of IRB


Anticipated trial start date

2011 Year 03 Month 01 Day

Last follow-up date

2013 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 03 Month 28 Day

Last modified on

2016 Year 03 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006338


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name